Drotaverine Hydrochloride & Aceclofenac Tablets (PLACIN-DR) | Amista Labs
Drotaverine Hydrochloride & Aceclofenac Tablets are a widely prescribed fixed-dose combination medication designed to address acute abdominal pain, smooth muscle spasms, and localized inflammation. By pairing a selective antispasmodic agent with a well-established non-steroidal anti-inflammatory drug (NSAID), Drotaverine Hydrochloride & Aceclofenac Tablets target both involuntary muscular contractions and prostaglandin-mediated pain pathways simultaneously.
For healthcare professionals, pharmacists, and pharmaceutical distributors evaluating reliable oral solid formulations, understanding the pharmacology and clinical profile of Drotaverine Hydrochloride & Aceclofenac Tablets is essential. Manufactured and marketed under strict quality protocols by Amista Labs, PLACIN-DR Tablets provide a standardized formulation combining Drotaverine Hydrochloride 80 mg and Aceclofenac 100 mg.
What Are PLACIN-DR Drotaverine Hydrochloride and Aceclofenac Tablets?
PLACIN-DR Tablets are prescription oral film-coated Drotaverine Hydrochloride & Aceclofenac Tablets formulated by Amista Labs containing two complementary active pharmaceutical ingredients: Drotaverine Hydrochloride 80 mg & Aceclofenac 100 mg.
Developed in facilities adhering to ISO 9001:2015 and WHO-GMP certified pharma company standards, PLACIN-DR is engineered to deliver consistent dissolution, reliable bioavailability, and moisture-protected blister packaging. Rather than relying on single-agent analgesia—which may relieve inflammation without relaxing painful smooth muscle spasms—Drotaverine Hydrochloride and Aceclofenac Tablets address both underlying physiological mechanisms under medical supervision.
Composition of Drotaverine Hydrochloride and Aceclofenac Tablets (PLACIN-DR)
Each film-coated tablet of PLACIN-DR (Drotaverine Hydrochloride & Aceclofenac Tablets) contains the following standardized active ingredients:
| Active Pharmaceutical Ingredient | Strength per Tablet | Pharmacological Classification | Primary Action |
| Drotaverine Hydrochloride | 80 mg | Selective Phosphodiesterase-4 (PDE-4) Inhibitor / Antispasmodic | Relaxes smooth muscle spasms in the gastrointestinal, biliary, urinary, and uterine tracts |
| Aceclofenac | 100 mg | Non-Steroidal Anti-Inflammatory Drug (NSAID) / COX-2 Preferential Inhibitor | Reduces prostaglandin synthesis to alleviate pain, swelling, and localized inflammation |
How Does Drotaverine Hydrochloride Work?
Drotaverine Hydrochloride is an isoquinoline derivative that acts as a direct-acting smooth muscle antispasmodic agent. Unlike anticholinergic antispasmodics (such as dicyclomine or hyoscine), Drotaverine exerts its therapeutic effect without binding to muscarinic receptors, thereby avoiding common anticholinergic side effects like dry mouth, blurred vision, or urinary retention.
Mechanism of Action of Drotaverine Hydrochloride
- Selective PDE-4 Inhibition: Drotaverine selectively inhibits the enzyme phosphodiesterase type 4 (PDE-4), which is responsible for degrading cyclic adenosine monophosphate (cAMP) within smooth muscle cells.
- Elevation of Intracellular cAMP: By preventing the breakdown of cAMP, intracellular cAMP levels rise, leading to the inactivation of myosin light-chain kinase (MLCK).
- Calcium Ion Modulation & Muscle Relaxation: Reduced MLCK activity decreases intracellular free calcium ion availability, prompting smooth muscle fibers in the gastrointestinal, biliary, renal, and genitourinary tracts to relax rapidly without impairing normal peristalsis.
How Does Aceclofenac Work?
Aceclofenac is a phenylacetic acid derivative belonging to the non-steroidal anti-inflammatory drug (NSAID) class, chemically related to diclofenac. It exhibits potent analgesic (pain-relieving), anti-inflammatory, and antipyretic properties with preferential selectivity toward the cyclooxygenase-2 (COX-2) enzyme over cyclooxygenase-1 (COX-1).
Mechanism of Action of Aceclofenac
- Inhibition of Prostaglandin Synthesis: Aceclofenac blocks the cyclooxygenase (COX) pathway, preventing the conversion of arachidonic acid into prostaglandins—the primary chemical mediators responsible for sensitizing pain receptors and triggering tissue inflammation.
- Suppression of Inflammatory Cytokines: Clinical pharmacology data indicates that Aceclofenac also downregulates pro-inflammatory cytokines such as interleukin-1$\beta$ (IL-1$\beta$) and tumor necrosis factor-alpha (TNF-$\alpha$), further reducing localized tissue edema and tenderness.
Therapeutic Role of the Drotaverine and Aceclofenac Combination
When formulated together in Drotaverine Hydrochloride and Aceclofenac Tablets, these two agents provide synergistic symptomatic relief for conditions characterized by concurrent smooth muscle spasm and inflammatory tissue pain:
- Dual-Pathway Pain Control: In visceral and colicky pain disorders, involuntary smooth muscle contraction compresses local nerve endings while tissue irritation triggers inflammatory prostaglandin release. Drotaverine relieves the mechanical spasm, while Aceclofenac dampens the biochemical inflammatory cascade.
- Improved Patient Compliance: Combining Drotaverine Hydrochloride 80 mg & Aceclofenac 100 mg into a single oral dose of Drotaverine Hydrochloride & Aceclofenac Tablets reduces pill burden compared to taking two separate medications, helping patients adhere strictly to their prescribed regimen.
Uses and Medical Applications of Drotaverine Hydrochloride and Aceclofenac Tablets
Healthcare practitioners prescribe Drotaverine Hydrochloride and Aceclofenac Tablets (such as PLACIN-DR) strictly based on clinical diagnosis for the short-term management of acute painful spasmodic conditions, including:
- Primary Dysmenorrhea (Menstrual Cramps): Drotaverine Hydrochloride & Aceclofenac Tablets help relieve painful uterine smooth muscle contractions and prostaglandin-induced pelvic inflammation during menstruation.
- Gastrointestinal Colic & Abdominal Spasms: Used in managing acute spasmodic abdominal pain associated with irritable bowel flare-ups, biliary colic, or non-ulcerative gastrointestinal spasms.
- Renal and Ureteric Colic: Assists in easing smooth muscle spasms and localized inflammation along the urinary tract during kidney stone passage, under close physician supervision.
- Post-Procedural or Gynecological Spasmodic Pain: Prescribed when clinicians identify both visceral muscular spasm and inflammatory discomfort following minor diagnostic or gynecological procedures.
Benefits of Understanding the PLACIN-DR Formulation
For prescribing physicians, retail pharmacists, and healthcare distributors partnering with a Pharmaceutical Tablet Manufacturer in India, clear product knowledge of Drotaverine Hydrochloride & Aceclofenac Tablets supports safe dispensing and better patient outcomes:
- Targeted Dual Relief: Addresses both spastic and inflammatory components of visceral pain in a single standardized tablet.
- Non-Anticholinergic Spasmolysis: Drotaverine’s selective PDE-4 mechanism avoids typical antimuscarinic adverse effects.
- Quality-Assured Manufacturing: Produced under stringent quality assurance systems by Amista Labs to ensure uniform drug content, stability, and batch-to-batch reliability.
Dosage and Administration Guidelines
The dosage and duration of Drotaverine Hydrochloride & Aceclofenac Tablets must be determined exclusively by a qualified physician based on the patient’s age, clinical condition, pain severity, and medical history.
- Administration Method: Swallow the PLACIN-DR tablet whole with a full glass of water. Do not crush, chew, or break the film-coated tablet unless specifically instructed by a healthcare provider.
- Food Intake: To minimize potential gastric irritation associated with the Aceclofenac (NSAID) component of Drotaverine Hydrochloride & Aceclofenac Tablets, physicians typically advise taking the tablet with or immediately after a meal.
- Duration of Therapy: Like all NSAID-containing formulations, Drotaverine Hydrochloride & Aceclofenac Tablets are generally prescribed at the lowest effective dose for the shortest duration necessary to control acute symptoms. Do not exceed the prescribed frequency or self-medicate beyond the recommended course.
Possible Side Effects and Precautions
While Drotaverine Hydrochloride & Aceclofenac Tablets are generally well tolerated when taken as directed, some individuals may experience mild-to-moderate adverse effects.
Common Possible Side Effects
- Nausea, indigestion (dyspepsia), heartburn, or mild epigastric discomfort
- Diarrhea or constipation
- Dizziness, lightheadedness, or mild drowsiness
- Dryness of the mouth or headache
Important Safety Precautions
- Gastrointestinal Monitoring: Prolonged or high-dose use of NSAIDs like Aceclofenac in Drotaverine Hydrochloride & Aceclofenac Tablets can increase the risk of gastritis, peptic ulceration, or gastrointestinal bleeding. Seek immediate medical attention if you notice black/tarry stools or persistent stomach pain.
- Blood Pressure & Dizziness: Drotaverine may occasionally cause mild vasodilation and transient hypotension (drop in blood pressure). Patients should avoid driving or operating heavy machinery if they feel dizzy after taking the tablet.
- Avoid Alcohol & Duplicate NSAIDs: Do not consume alcohol or take other painkillers (such as ibuprofen, diclofenac, or aspirin) concurrently with PLACIN-DR without explicit medical approval.
Who Should Avoid or Use Drotaverine Hydrochloride and Aceclofenac Tablets with Caution?
Certain patient populations have contraindications or require heightened clinical caution before taking Drotaverine Hydrochloride & Aceclofenac Tablets:
- Known Hypersensitivity: Individuals allergic to Drotaverine, Aceclofenac, aspirin, or any other NSAID (including those with a history of NSAID-induced asthma, urticaria, or angioedema) must avoid Drotaverine Hydrochloride & Aceclofenac Tablets.
- Active Peptic Ulcer or GI Bleeding: Contraindicated in patients with active stomach ulcers, gastrointestinal perforation, or a history of recurrent GI bleeding.
- Severe Hepatic, Renal, or Cardiac Impairment: Patients with severe liver disease, advanced kidney dysfunction, or severe congestive heart failure should not use this combination without specialist evaluation.
- Pregnancy and Breastfeeding: PLACIN-DR Tablets are generally contraindicated during pregnancy (especially in the third trimester due to risks of premature closure of the fetal ductus arteriosus) and are not recommended during lactation unless a physician determines that the potential benefit outweighs the risk.
- Pediatric Use: Not recommended for children unless specifically prescribed by a pediatrician.
Storage Instructions
Proper storage preserves the chemical stability and therapeutic potency of PLACIN-DR (Drotaverine Hydrochloride & Aceclofenac Tablets):
- Store in a cool, dry place at a temperature below $25^\circ\text{C}$ (or as printed on the blister strip).
- Protect from direct sunlight, heat, and excessive moisture.
- Keep the tablets inside their original aluminum/PVC blister packaging until the exact time of consumption.
- Keep out of sight and reach of children and pets. Never use expired tablets.
Why Choose Amista Labs for Pharmaceutical Products?
Founded in 2014 and headquartered in the Mohali/Chandigarh pharmaceutical hub, About Amista Labs reflects over a decade of commitment to accessible, quality-assured healthcare formulations across India. Recognized among the Best PCD Pharma Company in India, Amista Labs supports healthcare providers, wholesalers, and franchise entrepreneurs through:
- ISO 9001:2015 & WHO-GMP Aligned Quality: Every batch of Amista Labs Pharmaceutical Products—including PLACIN-DR Drotaverine Hydrochloride & Aceclofenac Tablets—undergoes rigorous quality control in third-party manufacturing and testing to verify purity, dissolution, and shelf-life stability.
- Comprehensive Product Portfolio: Beyond Drotaverine Hydrochloride & Aceclofenac Tablets, Amista Labs offers a diverse catalog spanning tablets, capsules, liquid syrups, dry syrups, sterile injectables, suspensions, softgels, eye drops, and Ayurvedic formulations.
- PCD Pharma Franchise & Third-Party Manufacturing: Entrepreneurs seeking a PCD Pharma Franchise Company in India or a Monopoly-Based PCD Pharma Franchise benefit from territory-exclusive rights, promotional kits, transparent pricing, and 24-hour dispatch logistics. Those exploring industry entry can also review our guide on How to Start a Pharma Franchise Business.

Frequently Asked Questions (FAQs) About Drotaverine Hydrochloride and Aceclofenac Tablets
1. What is the composition of PLACIN-DR Drotaverine Hydrochloride and Aceclofenac Tablets?
Each film-coated tablet of PLACIN-DR (Drotaverine Hydrochloride & Aceclofenac Tablets) contains Drotaverine Hydrochloride 80 mg (an antispasmodic agent) and Aceclofenac 100 mg (a non-steroidal anti-inflammatory pain reliever), formulated by Amista Labs.
2. What are Drotaverine Hydrochloride and Aceclofenac Tablets used for?
Drotaverine Hydrochloride and Aceclofenac Tablets are prescribed by doctors for the short-term relief of acute spasmodic and inflammatory pain, including menstrual cramps (primary dysmenorrhea), gastrointestinal colic, abdominal spasms, and renal or biliary colic.
3. Should PLACIN-DR Drotaverine Hydrochloride and Aceclofenac Tablets be taken before or after food?
It is generally recommended to take Drotaverine Hydrochloride & Aceclofenac Tablets (PLACIN-DR) with or immediately after food to reduce the likelihood of stomach upset or acidity caused by Aceclofenac. Always follow your prescribing doctor’s specific instructions.
4. Can I take Drotaverine Hydrochloride and Aceclofenac Tablets during pregnancy?
No, Drotaverine Hydrochloride & Aceclofenac Tablets are generally contraindicated during pregnancy—particularly in the third trimester—because NSAIDs like Aceclofenac can adversely affect fetal circulation and labor. Consult your obstetrician before taking any pain medication during pregnancy or breastfeeding.
5. Do Drotaverine Hydrochloride and Aceclofenac Tablets cause drowsiness?
While Drotaverine does not cause traditional anticholinergic sedation, mild dizziness or lightheadedness may occur in some individuals taking Drotaverine Hydrochloride & Aceclofenac Tablets. Avoid driving or operating machinery until you know how the medicine affects you.
6. Can I take other painkillers along with PLACIN-DR?
No, you should avoid taking other NSAIDs or over-the-counter pain relievers (such as ibuprofen, diclofenac, or mefenamic acid) alongside PLACIN-DR Drotaverine Hydrochloride & Aceclofenac Tablets, as combining NSAIDs increases the risk of stomach irritation and kidney strain.
7. How can distributors inquire about Amista Labs Pharmaceutical Products?
Pharmaceutical distributors, stockists, and franchise entrepreneurs can visit the official Amista Labs website or contact the business team directly to request the product catalog, net-rate list, and monopoly territory availability.
Conclusion
Drotaverine Hydrochloride and Aceclofenac Tablets represent a well-established dual-mechanism therapeutic option for managing acute smooth muscle spasms accompanied by inflammatory pain. By combining the selective PDE-4 inhibitory action of Drotaverine Hydrochloride 80 mg with the targeted anti-inflammatory efficacy of Aceclofenac 100 mg, PLACIN-DR (Drotaverine Hydrochloride & Aceclofenac Tablets) offers clinicians a reliable oral formulation when used strictly under appropriate medical guidance.
Backed by ISO 9001:2015 and WHO–GMP compliant quality standards, Amista Labs remains dedicated to delivering dependable, affordable formulations for patients and healthcare partners across India. For product inquiries, third-party manufacturing, or PCD pharma franchise partnerships, connect with Amista Labs today.
Users Today : 81
Users Yesterday : 134
Users This Month : 1098
Users This Year : 16060
